Perkins Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LeMaitre Vascular
LMAT
|
+$2.55M |
| 2 |
Abbott
ABT
|
+$2.4M |
| 3 |
ANI Pharmaceuticals
ANIP
|
+$1.24M |
| 4 |
CryoPort
CYRX
|
+$1.17M |
| 5 |
Deluxe
DLX
|
+$977K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$5.1M |
| 2 |
SVU
SUPERVALU Inc.
SVU
|
+$1.19M |
| 3 |
SRDX
Surmodics
SRDX
|
+$926K |
| 4 |
NVIDIA
NVDA
|
+$723K |
| 5 |
DTLK
Datalink Corp
DTLK
|
+$563K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.22% |
| 2 | Technology | 12.59% |
| 3 | Industrials | 9.45% |
| 4 | Energy | 3.46% |
| 5 | Communication Services | 3.14% |
Similar funds
Perkins Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Perkins Capital Management held 119 positions worth $96.9M, up 6.3% from $91.2M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Perkins Capital Management deployed $6.09M of net new capital in Q1 2017, opening 16 new positions and adding to 37 existing holdings. Its largest new stake was LeMaitre Vascular: 108,675 shares worth $2.68M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was NVIDIA, an estimated $723K trimmed.
- Perkins Capital Management's largest Q1 2017 buy was LeMaitre Vascular: 108,675 shares worth $2.68M.
- Perkins Capital Management added most to Abbott in Q1 2017, an estimated $2.4M increase.
- Perkins Capital Management's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $723K.
- Perkins Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $5.1M.
- Perkins Capital Management's ten largest holdings make up 35% of its $96.9M portfolio in Q1 2017.
- Perkins Capital Management opened 16 new positions and closed 8 in Q1 2017.
- Perkins Capital Management's portfolio value rose 6.3% quarter-over-quarter to $96.9M.
Based on Perkins Capital Management's 13F filing for Q1 2017, filed 19 Apr 2017.